Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Chang Chun St, Beijing, 100053, China.
International Neuroscience Institute (China-INI), Beijing, China.
BMC Endocr Disord. 2023 May 23;23(1):116. doi: 10.1186/s12902-023-01357-8.
Thyrotropin-secreting adenoma (TSHoma) is the least common type of pituitary adenoma, these patients often present with symptoms of hyperthyroidism. When TSHoma patients combined with autoimmune hypothyroidism, it is critically difficult to diagnose for the specific confusion in the results of thyroid function test.
One middle-aged male patient was presented with a sellar tumor on cranial MRI for headache symptoms. After hospitalization, a significant increase in thyrotropin (TSH) was revealed by the endocrine tests, while free thyronine (FT3) and free thyroxine (FT4) decreased, and the diffuse destruction of thyroid gland was revealed by thyroid ultrasound. Based on the endocrine test results, the patient was diagnosed as autoimmune hypothyroidism. After the multidisciplinary discussion, the pituitary adenoma was removed by endoscopic transnasal surgery, until the tumor was completely excised, for which TSHoma was revealed by postoperative pathology. A significant decrease of TSH was revealed by the postoperative thyroid function tests, the treatment for autoimmune hypothyroidism was conducted. After 20 months of follow-up, the thyroid function of patient had been improved significantly.
When the thyroid function test results of patients with TSHoma are difficult to interpret, the possibility of combined primary thyroid disease should be considered. TSHoma combined with autoimmune hypothyroidism is rare, which is difficult to diagnose. The multidisciplinary collaborative treatment could help to improve the outcomes of treatment.
促甲状腺激素瘤(TSHoma)是最不常见的垂体腺瘤类型,这些患者常出现甲亢症状。当 TSHoma 患者合并自身免疫性甲状腺功能减退症时,由于甲状腺功能检查结果的特异性混淆,诊断极具挑战性。
一名中年男性患者因头痛症状行头颅 MRI 检查发现鞍区肿瘤。住院后,内分泌检查显示促甲状腺激素(TSH)显著升高,游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)降低,甲状腺超声显示甲状腺弥漫性破坏。根据内分泌检查结果,患者被诊断为自身免疫性甲状腺功能减退症。经多学科讨论后,采用内镜经鼻蝶窦手术切除垂体瘤,直至肿瘤完全切除,术后病理显示 TSHoma。术后甲状腺功能检查显示 TSH 显著降低,给予自身免疫性甲状腺功能减退症治疗。随访 20 个月后,患者的甲状腺功能明显改善。
当 TSHoma 患者的甲状腺功能检查结果难以解释时,应考虑合并原发性甲状腺疾病的可能性。TSHoma 合并自身免疫性甲状腺功能减退症罕见,诊断困难。多学科协作治疗有助于改善治疗效果。